UnknownNot Applicable

Single Perclose Escalation Technique for Vascular Closure in TAVR

Spain300 participantsStarted 2023-07-19

Plain-language summary

This study examines in the safety and efficacy of using a single Perclose escalation technique (SPET) using a single Perclose Proglide device to preclose and the need for a rescue device based on a control angiography at the end of the procedure, with a 6F femoral sheath.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients older than 18 years * Patients who have undergone Transfemoral TAVI implantation Exclusion Criteria: * Patients who do not meet the inclusion criteria

What they're measuring

SAFETY:Incidence of Intrahospital Major Vascular Complications and Bleeding type 2 or type >2 (according to VARC 3 criteria)

Timeframe: 30 days

EFFICACY:Incidence of successful femoral closure

Timeframe: 30 days

Trial details

NCT IDNCT05836311

SponsorHospital Universitari Vall d'Hebron Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-02-19

Contact for this trial

VICENTE SERRA GARCIA, MD, PhD

0034932746155 vctsrr@hotmail.com

View on ClinicalTrials.gov More Aortic Valve Stenosis trials